Recombinant Human NAA10 Protein, MYC/DDK-tagged

• Cat.No.: NAA10-193H
• Product Overview: Recombinant human NAA10 protein, fused to MYC/DDK-tag at C-terminal, was expressed in HEK293.

Specification

• Description: N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012].
• Source: HEK293
• Species: Human
• Tag: MYC/DDK
• Form: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
• Molecular Mass: 26.3 kDa
• Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining
• Concentration: >50 ug/mL as determined by microplate BCA method

Gene Information

• Gene Name: N(alpha)-acetyltransferase 10, NatA catalytic subunit [ Homo sapiens ]
• Official Symbol: NAA10
• Synonyms: ARD1; ARD1A; ARD1P; DXS707; MCOPS1; NATD; OGDNS; TE2
• Gene ID: 8260
• mRNA Refseq: NM_003491.2
• Protein Refseq: NP_003482.1
• MIM: 300013
• UniProt ID: P41227